2015
London, UK, 14 December 2015 Unique LC Bead LUMI™ provides real-time visible confirmation of bead location during embolisation of hypervascular tumours and arteriovenous malformations BTG plc...
London, UK, 14 December 2015 BTG plc (LSE: BTG), the specialist healthcare company, today announces the successful outcome of the RENEW study, the pivotal US randomised controlled clinical trial...
London, UK, 11 December 2015 VISTOGARD is First and Only Treatment Available in US to Reverse Effects of and Prevent Death from Severe 5-FU Toxicity London, UK, December 11, 2015: BTG plc (LSE:...
12 November 2015 BTG plc: Interim Results - Replacement The following amendment has been made to the 'Half Yearly Report' announcement released on 10 November 2015 at 7am GMT under RNS No 1126F....
London, UK, 10 November 2015 BTG plc (LSE: BTG), the specialist healthcare company, today announces its interim results for the six months ended 30 September 2015. Click here to download the 10...
#, 12 October 2015 BTG plc (LSE: BTG), a global specialist healthcare company and Mirada Medical Ltd, a medical imaging software company, today announced an important collaboration to develop...
London, UK, 06 October 2015 BTG plc (LSE: BTG), the specialist healthcare company, announces the following update for the six months to 30 September 2015 ahead of the publication of its Interim...
Lisbon, Portugal, 27 September 2015 BTG plc company (LSE: BTG), announced promising data today for DC BeadM1™, supporting the efficacy and tolerability of doxorubicin-eluting DC BeadM1™ in the...
10 September 2015 BTG plc announced today that Wellstat Therapeutics’ new drug application (NDA) for uridine triacetate has been accepted for review by the United States Food and Drug...
London, UK, 09 September 2015 BTG, the specialist healthcare company, took up the Trekfest Challenge in the Peak District (5-6 September) for The Royal Marsden Cancer Charity and expects to raise...
Bothell, WA, USA, 24 August 2015 Results show no intracranial hemorrhage, no death among massive PE patients EKOS Corporation, a BTG International group company (BTG plc; LSE: BTG), announced the...
London, UK, 06 August 2015 BTG plc (LSE: BTG), the specialist healthcare company, today announces that Health Canada has issued a Notice of Compliance approving Varithena™ (polidocanol...
15 July 2015 BTG plc (LSE: BTG), the specialist healthcare company, announces the following business update ahead of its Annual General Meeting, which will be held today at 10.30 am at the offices...
Bothell, WA, 09 July 2015 EKOS™ Corporation, a privately held medical device company located in Bothell, Washington, announced the results of DUET, the world’s first and only multicenter...
15 June 2015 In accordance with the Listing Rule 9.6.1, copies of the following documents have been submitted to the UK Listing Authority. A copy of the Company's Annual Report and Accounts for...
London, UK, 10 June 2015 BTG plc (LSE: BTG), the specialist healthcare company, today announced the treatment of the first patient in Singapore with TheraSphere®, a treatment for primary liver...
London, 19 May 2015 BTG plc (LSE: BTG), the specialist healthcare company, notes the presentation of top line data showing that REVOLENS, a randomized, controlled trial sponsored by the French...
London, UK, 19 May 2015 BTG plc (LSE:BTG), the specialist healthcare company, today announces the launch of a sponsored Level 1 American Depositary Receipt (ADR) programme. The ADR programme will...
London UK, 19 May 2015 BTG plc (LSE: BTG), the specialist healthcare company, today announces its final results for the year ended 31 March 2015. Click here to download the results release PDF
London, UK, 02 April 2015 BTG plc (LSE:BTG), the specialist healthcare company, provides the following update for the year ended 31 March 2015 ahead of the publication of its Final Results on 19...
London, UK, 01 April 2015 BTG plc (LSE: BTG), the specialist healthcare company, today began selling its drug-eluting bead and embolisation products, DC Bead® and Bead Block®, directly to...
London, UK, 05 February 2015 BTG plc (LSE: BTG), the specialist healthcare company, announces updated revenue guidance for the year ending 31 March 2015. BTG's overall performance during the year...
London, UK, 08 January 2015 BTG plc (LSE: BTG), the specialist healthcare company, announced on 4 December 2014 that it had entered into an agreement to buy PneumRx Inc, a growing interventional...